Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

AcelRx Pharmaceuticals, Inc.

ACRX•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$0.86
$0.06(7.50%)
U.S. Market opens in 12h 22m

AcelRx Pharmaceuticals, Inc. (ACRX) Stock Overview

Explore AcelRx Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap14.6M
P/E Ratio-2.88
EPS (TTM)$-2.75
ROE-1.26%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

ACRX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of AcelRx Pharmaceuticals, Inc. (ACRX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -2.88 and a market capitalization of 14.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
-18.10%
1-Month Change
7.50%
3-Month Change
62.23%
6-Month Change
-9.47%
Year-to-Date (YTD) Change
16.15%
1-Year Change
-55.67%
3-Year Change
-98.34%
5-Year Change
-98.29%
All-Time (Max) Change
-99.05%

Contact Information

https://www.acelrx.com
650 216 3500
25821 Industrial Boulevard, Hayward, CA, 94545

Company Facts

190 Employees
IPO DateFeb 11, 2011
CountryUS

Frequently Asked Questions